Xeris Biopharma Holdings, Inc. XERS Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s net debt?
- Xeris Biopharma Holdings, Inc. (XERS) reported net debt of $146.8M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s net debt changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s net debt decreased by 30.2% year-over-year, from $210.31M to $146.8M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s net debt?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s net debt has grown at a 24.4% compound annual growth rate (CAGR), from $49.42M to $147.06M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.